MX9100967A - Uso del complejo de iones metalicos radioactivos con allcis-1,3,5-triamino-2,4,5-ciclohexanotriol y sus derivados para propositos de diagnosticos por rayos x y en la terapia de tumores asi como en la preparacion de medios para propositos de - Google Patents

Uso del complejo de iones metalicos radioactivos con allcis-1,3,5-triamino-2,4,5-ciclohexanotriol y sus derivados para propositos de diagnosticos por rayos x y en la terapia de tumores asi como en la preparacion de medios para propositos de

Info

Publication number
MX9100967A
MX9100967A MX9100967A MX9100967A MX9100967A MX 9100967 A MX9100967 A MX 9100967A MX 9100967 A MX9100967 A MX 9100967A MX 9100967 A MX9100967 A MX 9100967A MX 9100967 A MX9100967 A MX 9100967A
Authority
MX
Mexico
Prior art keywords
purposes
cycllohexanotriol
allcis
triamino
derivatives
Prior art date
Application number
MX9100967A
Other languages
English (en)
Spanish (es)
Inventor
Isidor Erni
Walter Schneider
Hans Kaspar Heggetschweiler
Peter Geisser
Original Assignee
Hausmann Ag Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hausmann Ag Labor filed Critical Hausmann Ag Labor
Publication of MX9100967A publication Critical patent/MX9100967A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9100967A 1990-09-05 1991-09-05 Uso del complejo de iones metalicos radioactivos con allcis-1,3,5-triamino-2,4,5-ciclohexanotriol y sus derivados para propositos de diagnosticos por rayos x y en la terapia de tumores asi como en la preparacion de medios para propositos de MX9100967A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4028139A DE4028139A1 (de) 1990-09-05 1990-09-05 Verwendung der komplexe radioaktiver metallionen mit all-cis-1,3,5-triamino-2,4,6-cyclohexantriol und seinen derivaten fuer roentgendiagnostische zwecke und in der tumortherapie sowie zur herstellung von mitteln fuer roentgendiagnostische zwecke und fuer die tumortherapie

Publications (1)

Publication Number Publication Date
MX9100967A true MX9100967A (es) 1992-05-04

Family

ID=6413642

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100967A MX9100967A (es) 1990-09-05 1991-09-05 Uso del complejo de iones metalicos radioactivos con allcis-1,3,5-triamino-2,4,5-ciclohexanotriol y sus derivados para propositos de diagnosticos por rayos x y en la terapia de tumores asi como en la preparacion de medios para propositos de

Country Status (10)

Country Link
EP (1) EP0504339A1 (enExample)
JP (1) JPH05502456A (enExample)
KR (1) KR920702235A (enExample)
AU (1) AU658148B2 (enExample)
CA (1) CA2073050A1 (enExample)
DE (1) DE4028139A1 (enExample)
MX (1) MX9100967A (enExample)
PT (1) PT98869A (enExample)
TW (1) TW197951B (enExample)
WO (1) WO1992004056A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
EP2849804A1 (en) * 2012-05-18 2015-03-25 Bayer Pharma Aktiengesellschaft Bis azainositol heavy metal complexes for x-ray imaging
EP2796152A1 (en) 2013-04-25 2014-10-29 Bayer Pharma Aktiengesellschaft Unsymmetrical Bis Azainositol Hafnium Complexes for X-Ray Imaging
EP2873670A1 (en) 2013-11-14 2015-05-20 Bayer Pharma Aktiengesellschaft Bis azainositol zirconium complexes for X-ray imaging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3503614A1 (de) * 1985-02-02 1986-08-07 Laboratorien Hausmann AG, St. Gallen All-cis-1,3,5-triamino-2,4,6-cyclohexantriol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
CH679742A5 (enExample) * 1990-01-09 1992-04-15 Byk Gulden Lomberg Chem Fab

Also Published As

Publication number Publication date
AU8436791A (en) 1992-03-30
WO1992004056A1 (de) 1992-03-19
JPH05502456A (ja) 1993-04-28
CA2073050A1 (en) 1992-03-06
KR920702235A (ko) 1992-09-03
DE4028139A1 (de) 1992-03-12
EP0504339A1 (de) 1992-09-23
PT98869A (pt) 1992-07-31
TW197951B (enExample) 1993-01-11
AU658148B2 (en) 1995-04-06

Similar Documents

Publication Publication Date Title
IL55362A0 (en) An x-ray colimator for use in axial tomography apparatus
YU38680A (en) Process for preparing diagnostic agent for proving leukocites presence in body liquids
EP0461776A3 (en) X-ray analysis apparatus, especially computer tomography apparatus and x-ray target and collimator therefor
EP0447879A3 (en) High precision x-ray collimator
ZA807688B (en) Annihilation radiation analysis
GB2058510B (en) Positron annihilation imaging device having movable collimator
AU8681482A (en) Method for diagnosing and for the therapeutic treatment of tumors and/or infectious deseases of different types with the preparative use of alkaloid-compounds or their salts
AR230060A1 (es) Procedimiento para la preparacion de 3-aminosianonimias substituidas,aminoacetonitrilo substituido para su uso exclusivo en dicho procedimiento y procedimiento para su preparacion
NO163435C (no) Pasientstol for roentgenundersoekelser.
PH16228A (en) Triazolo pyridazine derivatives,pharmaceutical composition containing the same and their use
GB2108657B (en) Device for the measurement of the radiation dose versus depth in soft tissues
MX9100967A (es) Uso del complejo de iones metalicos radioactivos con allcis-1,3,5-triamino-2,4,5-ciclohexanotriol y sus derivados para propositos de diagnosticos por rayos x y en la terapia de tumores asi como en la preparacion de medios para propositos de
IT8349080A0 (it) Pigiama munito di aperture chiudibili per la ispezione corporea, in particolare per pazienti degenti
WO1997005904A3 (de) Verwendung von metall-clustern als kontrastmittel oder strahlentherapeutikum
AU517665B2 (en) N-glucofuranosid-6-yl-n3-nitroso-ureas and their use in the treatment of tumours and leukaemia
IT1173473B (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni,in particolare per l'uso nel trattamento di psoriasi
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
IT1142720B (it) Perfezionamento nei meccanismi di reclinazione della spalliera per sedili di automobili
Hayes et al. Compartmentalized phantoms for the standard man, adolescent and child
IT7869661A0 (it) Apparecchio per l'irradiazione di raggi ultravioletti,particolarmente per uso medico o cosmetico
IT1170862B (it) Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
GB2198150B (en) Membrane for use in x-ray mask and method for preparing the same
DE3061631D1 (en) Electrochemical process for the preparation of 4-tert.-butoxy-benzaldehyde-dialkylacetals, their use and 4-tert.-butoxy-benzaldehyde-dimethylacetal
FR2467581B1 (fr) Appareil de localisation d'une region dans le corps humain, en particulier d'un thrombus veineux, par l'absorption d'une substance radio-active, notamment l'i 125
ZA786908B (en) In vitro testing method for the diagnosis of malignant tumours